Lancet Oncol:BHGI从不停下改善医疗健康的脚步

2014-12-22 MedSci MedSci原创

  Lancet Oncol:BHGI从不停下改善医疗健康的脚步 随着医学的进步,基于循证医学指南、最佳的诊断、治疗技术使得发达国家的乳腺癌患者可以早期诊断和治疗并被国家肿瘤控制计划严格实施,然而由于卫生条件的限制、医疗系统的落后,中低收入国家(LMICs)对指南的实施却障碍重重。 为提高LMICs在现有的卫生系统下的乳腺癌患者得到较好的诊治,乳房健康全球倡议(BHGI)组织

随着医学的进步,基于循证医学指南、最佳的诊断、治疗技术使得发达国家的乳腺癌患者可以早期诊断和治疗并被国家肿瘤控制计划严格实施,然而由于卫生条件的限制、医疗系统的落后,中低收入国家(LMICs)对指南的实施却障碍重重。 为提高LMICs在现有的卫生系统下的乳腺癌患者得到较好的诊治,乳房健康全球倡议(BHGI)组织从2002年起就带领全世界的专家举行了一系列国际会议,旨在商议为LMICs量身定制乳腺癌诊治指南,为了解这些国家对指南的宣传、实施及运用情况,本文将做一阐述。 本研究通过检索文章的形式,最终纳入552篇与BHGI相关文献(除去重复的、不相关的及BHGI成员的文章),其中有200篇(36%)是叙述BHGI指南的文章,有159(29%)是关于早期诊断的,剩余的很小一部分是关于诊断、治疗及期望医改的文章。 就文章的来源而言,283(51%)是关于撒哈拉以南非洲地区,71篇(13%)是关于亚洲,71篇(13%)是关于拉丁美洲,50篇(9%)关于中东。就应用目的而言,375(68%)是关于疾病处理方式,并指出BHGI指南能提高诊疗进程。约1/4的文章指出该指南能为LMICs建立流行病学信息

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1864578, encodeId=c53818645e8da, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sat Jul 11 00:03:00 CST 2015, time=2015-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827956, encodeId=69c8182e95663, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Aug 13 08:03:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16022, encodeId=6ea9160226e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:28:00 CST 2015, time=2015-02-16, status=1, ipAttribution=)]
    2015-07-11 minlingfeng
  2. [GetPortalCommentsPageByObjectIdResponse(id=1864578, encodeId=c53818645e8da, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sat Jul 11 00:03:00 CST 2015, time=2015-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827956, encodeId=69c8182e95663, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Aug 13 08:03:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16022, encodeId=6ea9160226e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:28:00 CST 2015, time=2015-02-16, status=1, ipAttribution=)]
    2015-08-13 howi
  3. [GetPortalCommentsPageByObjectIdResponse(id=1864578, encodeId=c53818645e8da, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sat Jul 11 00:03:00 CST 2015, time=2015-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1827956, encodeId=69c8182e95663, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Aug 13 08:03:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16022, encodeId=6ea9160226e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:28:00 CST 2015, time=2015-02-16, status=1, ipAttribution=)]
    2015-02-16 Johnny1989

    谢谢分享!

    0